Skip to main content
. Author manuscript; available in PMC: 2018 May 15.
Published in final edited form as: Cancer Res. 2017 Sep 26;77(22):6321–6329. doi: 10.1158/0008-5472.CAN-17-1589

Figure 6. Kaplan-Meier survival plots for PHGDH gene amplification groups in a TCGA cohort.

Figure 6

A, Overall survival (left) and Disease-free survival periods (right) were significantly reduced in the patients with PHGDH gene amplification in comparison to patients without amplification (P =0.0003 and P = 0.0329 respectively). B, Cox proportional analysis for the prediction of overall survival, and summary of the analysis.